Compounds > tiletamine hydrochloride
Page last updated: 2024-08-22

tiletamine hydrochloride and Colorectal Cancer

tiletamine hydrochloride has been researched along with Colorectal Cancer in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, HP; Chen, YJ; Cheng, YJ; Hou, MF; Lee, YC; Lin, YH; Liu, KW; Wu, YC; Yuan, SS1
Adebayo, BO; Chang, TC; Deng, L; Hsiao, M; Huang, CC; Lee, WH; Lin, YC; Rao, YK; Tzeng, YM; Wang, LS; Wu, AT; Wu, CH; Yeh, CT1
Evans, H; Huber, K; Lakhani, N; Martin, S; Mukherjee, A1
Adlercreutz, H; Andersson, LC; Attalla, H; Mäkelä, TP; Rasku, S; Wähälä, K1

Other Studies

4 other study(ies) available for tiletamine hydrochloride and Colorectal Cancer

ArticleYear
The synthetic flavonoid WYC02-9 inhibits colorectal cancer cell growth through ROS-mediated activation of MAPK14 pathway.
    Life sciences, 2013, Jun-13, Volume: 92, Issue:22

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Cyclohexanones; Drug Screening Assays, Antitumor; Female; Flavones; Gene Knockdown Techniques; Humans; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 14; Neoplasm Transplantation; Plant Extracts; Reactive Oxygen Species; Transplantation, Heterologous; Xenograft Model Antitumor Assays

2013
4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype.
    Toxicology and applied pharmacology, 2015, Oct-15, Volume: 288, Issue:2

    Topics: 4-Butyrolactone; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Colorectal Neoplasms; Cyclohexanones; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Leucovorin; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Organoplatinum Compounds; Phenotype; Signal Transduction; Spheroids, Cellular; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays

2015
A cellular and molecular investigation of the action of PMX464, a putative thioredoxin inhibitor, in normal and colorectal cancer cell lines.
    British journal of pharmacology, 2007, Volume: 151, Issue:8

    Topics: Apoptosis; Benzothiazoles; Cell Cycle; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Cyclohexanones; Drug Delivery Systems; Endothelium, Vascular; Fibroblasts; Humans; Thioredoxins; Umbilical Veins

2007
2,6-Bis((3,4-dihydroxyphenyl)-methylene)cyclohexanone (BDHPC)-induced apoptosis and p53-independent growth inhibition: synergism with genistein.
    Biochemical and biophysical research communications, 1997, Oct-20, Volume: 239, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Catechols; Colorectal Neoplasms; Cyclohexanones; Drug Synergism; G1 Phase; Genistein; Growth Inhibitors; Humans; Jurkat Cells; Tumor Cells, Cultured; Tumor Suppressor Protein p53

1997